Belite Bio (BLTE) director details stock option grants and vesting

Rhea-AI Filing Summary

Belite Bio director Gary Clark Biddle filed an initial ownership report showing stock option holdings in the company. He holds options covering 50,000 ordinary shares at an exercise price of $6.00 per share, expiring on April 17, 2032. This option vests over three years: 20,000 shares vest in 12 equal monthly installments after April 28, 2022, and the remaining 30,000 vest in 24 monthly installments after the first anniversary of that date, all subject to continued service. He also holds options over 60,000 ordinary shares at an exercise price of $58.88 per share, expiring on April 14, 2035, which vest in 36 equal monthly installments after April 15, 2025, subject to continued service. The filing lists these option positions and vesting terms rather than reporting any share purchases or sales.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Biddle Gary Clark

(Last) (First) (Middle)

UNIT 602, 296 FLINDERS STREET

(Street)

MELBOURNE AUSTRALIA 3000

(City) (State) (Zip)

AUSTRALIA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
BELITE BIO, INC [ BLTE ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	(1)	04/17/2032	Ordinary Shares	50,000	$6	D
Stock Option (right to buy)	(2)	04/14/2035	Ordinary Shares	60,000	$58.88	D

Explanation of Responses:

1. The option shall vest (i) as to 20,000 ordinary shares subject to the option in 12 equal and continuous monthly installments for each full month of services completed following April 28, 2022, and (ii) as to the remaining 30,000 ordinary shares subject to the option in 24 equal and continuous monthly installments for each full month of services completed following the first anniversary of April 28, 2022, subject to continued service to the Issuer on each such date.

2. The option shall vest as to 60,000 ordinary shares subject to the option in 36 equal and continue monthly installments for each full month of services completed following April 15, 2025, subject to continued service to the Issuer on such date.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Gary Clark Biddle	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)